Methods for treating congestive heart failure

Details Methods for treating congestive heart failure Methods for treating congestive heart failure

2009-12-29

2011-12-13

Wen, Sharon (Department: 1644)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S008100

Reexamination Certificate

active

08076283

ABSTRACT:
The invention features methods of treating or preventing congestive heart failure by administering a polypeptide containing an epidermal growth factor-like domain encoded by a neuregulin gene.

REFERENCES:
patent: 3773919 (1973-11-01), Boswell et al.
patent: 4179337 (1979-12-01), Davis et al.
patent: 4301144 (1981-11-01), Iwashita et al.
patent: 4485045 (1984-11-01), Regen
patent: 4496689 (1985-01-01), Mitra
patent: 4544545 (1985-10-01), Ryan et al.
patent: 4640835 (1987-02-01), Shimizu et al.
patent: 4670417 (1987-06-01), Iwasaki et al.
patent: 4791192 (1988-12-01), Nakagawa et al.
patent: 5367060 (1994-11-01), Vandlen et al.
patent: 5530109 (1996-06-01), Goodearl et al.
patent: 5641869 (1997-06-01), Vandlen et al.
patent: 5667780 (1997-09-01), Ho et al.
patent: 5714385 (1998-02-01), Mather et al.
patent: 5716930 (1998-02-01), Goodearl et al.
patent: 5721139 (1998-02-01), Mather et al.
patent: 5834229 (1998-11-01), Vandlen et al.
patent: 5840525 (1998-11-01), Vandlen et al.
patent: 5856110 (1999-01-01), Vandlen et al.
patent: 5859206 (1999-01-01), Vandlen et al.
patent: 5968511 (1999-10-01), Akita et al.
patent: 6033660 (2000-03-01), Mather et al.
patent: 6087323 (2000-07-01), Gwynne et al.
patent: 6096873 (2000-08-01), Schaefer et al.
patent: 6121415 (2000-09-01), Godowski et al.
patent: 6136558 (2000-10-01), Ballinger et al.
patent: 6156728 (2000-12-01), Gao
patent: 6162641 (2000-12-01), Goldman et al.
patent: 6169070 (2001-01-01), Chen et al.
patent: 6252051 (2001-06-01), Godowski et al.
patent: 6387638 (2002-05-01), Ballinger et al.
patent: 6399746 (2002-06-01), Vandlen et al.
patent: 6444642 (2002-09-01), Sklar et al.
patent: 6446242 (2002-09-01), Lien et al.
patent: 6593290 (2003-07-01), Gao
patent: 6635249 (2003-10-01), Marchionni et al.
patent: 6750196 (2004-06-01), Reh et al.
patent: 7037888 (2006-05-01), Sklar et al.
patent: 7226907 (2007-06-01), Zhou
patent: B-68278/94 (1994-12-01), None
patent: 3218121 (1982-05-01), None
patent: 0 102 324 (1984-03-01), None
patent: 0 133 988 (1984-08-01), None
patent: 0 052322 (1985-03-01), None
patent: 0 058481 (1986-10-01), None
patent: 0 088 046 (1987-12-01), None
patent: 0 143 949 (1988-10-01), None
patent: 0 036 676 (1990-09-01), None
patent: 0 142 641 (1991-01-01), None
patent: 0 647 449 (1994-06-01), None
patent: 58-118008 (1985-01-01), None
patent: WO 89/01489 (1989-02-01), None
patent: WO 92/18627 (1992-10-01), None
patent: WO 94/00140 (1994-01-01), None
patent: WO 94/26298 (1994-11-01), None
patent: WO 95/32724 (1995-12-01), None
patent: WO 96/15812 (1996-05-01), None
patent: WO 97/09425 (1997-03-01), None
patent: WO 99/03973 (1999-01-01), None
patent: WO 99/18976 (1999-04-01), None
Burden et al., Neuregulins and Their Receptors: A Versatile Signalling Module in Organogenesis and Oncogenesis, Neuron, 18:847-855 (1997).
Busfield et al., Characterization of a Neuregulin-Related Gene,Don-1, That is Highly Expressed in Related Regions of the Cerebellum and Hippocampus, Mol. Cell. Biol., 17:4007-4014 (1997).
Caraway et al., Neuregulin-2, a new ligand of ErbB3/Erb84-Receptor Tyrosine Kinases, Nature, 387:512-516 (1997).
Chang et al., Ligand for ErB-family Receptors Encoded by a Neuregulin-like Gene, Nature, 387:509-512 (1997).
Holmes et al., Identification of Heregulin, A Specific Activator of p185erbB2,Science 256:1205-1210 (1992).
Lemke, Neuregulins in Development, Mol. Cell. Neurosci. 7;247-262 (1996).
Marchionni et al., Glial Growth Factors are Alternatively Spliced erbB2 Ligands expressed in the Nervous System, Nature 362:312-318 (1993).
Meyer et al., Isoform-specific Expresion and Function of Neuregulin, Development 124:3575-3586 (1997).
Peles et al., Isolation of the NeuHER-2 Stimulatory Ligand: A 44 kd Glycoprotein that Induces Differentiation of Mammary Tumor Cells, Cell 69:205-216 (1992).
Bargmann et al., “The Neu oncogene encodes an epidermal growth factor receptor-related protein” Nature 319:226-230, 1986.
Chen et al., Expression of Multiple Neuregulin Transcripts in Postnatal Rat Brains: J. Comp. Neurol. 349: 389-400, 1994.
Corfas et al., “Differential Expression of ARIA Isoforms in the Rat Brain” Neuron 14: 103-115, 1995.
Falls et al., “ARIA, A Protein that Stimulates Acetylcholine Receptor Synthesis, is a member of the Neu ligand Family” Cell 72: 801-815, 1993.
Higashiyama et al., “A novel brain-derived member of the epidermal growth factor family that interacts with ErbB3 and ErbB4” J. Biochem. (Tokyo) 122:675-680, 1997.
Hijazi et al., NRG-3 in human breast cancers: activation of multiple erbB family proteins: Int. J. Oncol. 13:1051-1067, 1998.
Kraus, et al., Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors Proc. Natl. Acad. Sci. USA 86: 9193-9197, 1989.
Meyer et al., “Distinct Isoforms of neuregulin are expressed in mesenchymal and neuronal cells during mouse development” Proc. Natl. Acad. Sci. USA 91: 1064-1068, 1994.
Orr-Urtreger et al., “Neural expression and chromosomal mapping of Neu differentiation factor to 8p12-p21” Proc. Natl. Acad. Sci. USA 90: 1867-1871, 1993.
Plowman et al., “Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family” Proc. Natl. Acad. Sci. USA 90: 1746-1750, 1993.
Sarker et al., “Quantitative analysis of Her-2
eu (ERBB2) gene expression using reverse transcriptase polymerase chain reaction” Diagn. Mol. Pathol. 2:210-218, 1993.
U.S. Appl. No. 08/461,097, filed 1995.
Wen et al., Neu Differentiation Factor: A Transmembrance Glycoprotein Containing an EGF Domain and an Immunoglobulin Homology Unit Cell 69:559-572, 1992.
Zhao et al., “Neuregulins Promote Survival and Growth of Cardiac Myocytes.” Journal of Biological Chemistry 273:10261-10269, 1998.
Peles and Yarden, Neu and its Ligands: From an Oncogene to Neural factors, BioEssays 15:815-824 (1993).
Pinkas-Kramarski et al., Differential Expression of NDF
euregulin reeptors ErbB-3 and ErbB-4 and involvement in inhibition of Neuronal Differential, Oncogene 15:2803-2815 (1997).
Pinkas-Kramarski et al., Brain Neurons and Glial Cells Express neu Differential Factor/Heregulin: A Survival Factor for Astrocytes, Proc. Natl. Acad. Sci. USA 91:9387-9391 (1994).
Pinkas-Kramarski et al., ErbB Tyrosine Kinases and the Two Neuregulin Families Constitute a Ligand-Receptor network, Mol. Cell. Biol. 18:6090-6101 (1998).
Zhang et al., Neuregulin-3 (NRG3): A Novel Neural Tissue-Enriched Protein That Binds and Activates ErbB4, Proc. Natl. Acad. Sci USA 94:9562-9567 (1997).
The Merck Manual of Diagnosis and Therapy, 17th Edition, pp. 1682-1692 (1999).
Balligand et al., Cardiac Endothelium and Tissue Growth, Progress in Cardiovascular Diseases, 39:351-360 (1997).
Chien et al., Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response, The FASEB Journal, 5:3037-3046 (1991).
Dias et al., The Molecular Basis of Skeletal Muscle Differentiation, Seminars in Diagnostic Pathology, 11:3-14 (1994).
Epstein et al., Biological activity of liposome-encapsulated murine interferon γ is mediated by a cell membrane receptor, Proc. Natl. Acad. Sci. USA, 82:3688-3692 (1985).
Florini et al., Stimulation of Myogenic Differentiation by a Neuregulin, Glial Growth Factor 2, J. Biol. Chem., 271:12699-12702 (1996).
Hwang et al., Hepatic uptake and degradation of unilamellar sphingomyelin/cholesterol liposomes: A kinetic study, Proc. Natl. Acad. Sci. USA, 77:4030-4034 (1980).
Langer et al., Biocompatibilty of polymeric delivery systems for macromolecules, Journal of Biomedical Material Research, 15:267-277 (1981).
Parker et al., p53-Independent Expression of p21Cip1in Muscle and Other Terminally Differentiating Cells, Science, 267:1024-1027 (1995).
Physician's Desk Reference, Medical Economics Data Production Co., Montvale, NJ, 2314-2320 (1994).
Rumyantsev, Interrelations of the Proliferation and Differe

Affiliated with

Also associated with

Rating

Methods for treating congestive heart failure does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for treating congestive heart failure, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for treating congestive heart failure will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4272667